Metrics other than potency reveal systematic variation in responses to cancer drugs - Dataset (ID:20120)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10255-1 | GSK1838705A | LSM-4276 | 25182616 | ||
10252-1 | Gemcitabine | Gemzar | LSM-5333 | 60750 | |
10251-1 | Fascaplysin | LSM-4272 | 73293 | ||
10250-1 | Etoposide | LSM-6348 | 36462 | ||
10249-1 | Epirubicin | Ellence | LSM-2078 | 41867 | |
10248-1 | Doxorubicin | Adriamycin | LSM-4062 | 31703 | |
10247-1 | Docetaxel | Taxotere | LSM-6360 | 148124 | |
10246-1 | CPT-11 | Irinotecan | LSM-2167 | 60838 | |
10245-1 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 | ||
10244-1 | CGC-11144 | LSM-4267 | 6476700 | ||
10243-1 | CGC-11047 | PG11047 | LSM-4266 | 476863 | |
10242-1 | Carboplatin | LSM-44959 | 5237030 | ||
10241-1 | Bortezomib | Velcade | LSM-6281 | 387447 | |
10238-1 | 5-FU | Fluorouracil | LSM-4261 | 3385 | |
10237-1 | 5-DFUR | 5-FdUR; Doxifluridine | LSM-6359 | 18343 | |
10236-1 | 17-AAG | Tanespimycin | LSM-43239 | 151069 | |
10235-2 | Everolimus | RAD001 | LSM-4258 | 53398658 | |
10230-2 | Lestaurtinib | CEP-701 | LSM-1231 | 126565 | |
10228-2 | IKK16 | LSM-2309 | 9549298 | ||
10223-2 | AG1478 | Tyrphostin | LSM-1224 | 2051 | |
10189-2 | Bosutinib | SKI-606 | LSM-1190 | 5328940 | |
10175-3 | Sunitinib | Sutent; SU11248 | LSM-42800 | 3086686 | |
10172-2 | GSK1059615 | LSM-1173 | 71317162 | ||
10146-2 | Omipalisib | GSK2126458; GSK2126458A | LSM-1147 | 25167777 | |
10142-2 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 | 11707110 |